Cargando…

SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women

BACKGROUND/HYPOTHESIS: SMARTWOMAN™ was designed to develop and assess the feasibility of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women. METHODS: Fourteen African‐American women with diabetes and without known cardiovascular disease were enrolled. A weight‐scale...

Descripción completa

Detalles Bibliográficos
Autores principales: Wenger, Nanette K., Williams, Olubunmi O., Parashar, Susmita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712310/
https://www.ncbi.nlm.nih.gov/pubmed/30471130
http://dx.doi.org/10.1002/clc.23124
_version_ 1783446654399021056
author Wenger, Nanette K.
Williams, Olubunmi O.
Parashar, Susmita
author_facet Wenger, Nanette K.
Williams, Olubunmi O.
Parashar, Susmita
author_sort Wenger, Nanette K.
collection PubMed
description BACKGROUND/HYPOTHESIS: SMARTWOMAN™ was designed to develop and assess the feasibility of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women. METHODS: Fourteen African‐American women with diabetes and without known cardiovascular disease were enrolled. A weight‐scale, glucometer, sphygmomanometer, and FitBit were synchronized to the smartphone, and text messaging was provided. Follow‐up was 6 months. RESULTS: Patients were able to follow instructions for app use and device prompts. Weekly device reporting was 85% for blood glucose, 82.5% for daily steps, and 77% for systolic blood pressure. Patient engagement levels were 85% to 100% at 1 month and 50% to 78% at month 6. The majority reported text messages to be useful, easy to understand, and appropriate in frequency. The women indicated on the exit questionnaire that study participation increased their motivation and ability to take charge of their health. CONCLUSIONS: Use of a smartphone app to control cardiovascular risk factors appears feasible in a population of vulnerable indigent African‐American diabetic women, resulted in increased patient satisfaction and positive reinforcement to healthy behaviors, and warrants a larger clinical outcome trial.
format Online
Article
Text
id pubmed-6712310
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wiley Periodicals, Inc.
record_format MEDLINE/PubMed
spelling pubmed-67123102019-08-28 SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women Wenger, Nanette K. Williams, Olubunmi O. Parashar, Susmita Clin Cardiol Clinical Investigations BACKGROUND/HYPOTHESIS: SMARTWOMAN™ was designed to develop and assess the feasibility of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women. METHODS: Fourteen African‐American women with diabetes and without known cardiovascular disease were enrolled. A weight‐scale, glucometer, sphygmomanometer, and FitBit were synchronized to the smartphone, and text messaging was provided. Follow‐up was 6 months. RESULTS: Patients were able to follow instructions for app use and device prompts. Weekly device reporting was 85% for blood glucose, 82.5% for daily steps, and 77% for systolic blood pressure. Patient engagement levels were 85% to 100% at 1 month and 50% to 78% at month 6. The majority reported text messages to be useful, easy to understand, and appropriate in frequency. The women indicated on the exit questionnaire that study participation increased their motivation and ability to take charge of their health. CONCLUSIONS: Use of a smartphone app to control cardiovascular risk factors appears feasible in a population of vulnerable indigent African‐American diabetic women, resulted in increased patient satisfaction and positive reinforcement to healthy behaviors, and warrants a larger clinical outcome trial. Wiley Periodicals, Inc. 2019-01-17 /pmc/articles/PMC6712310/ /pubmed/30471130 http://dx.doi.org/10.1002/clc.23124 Text en © 2018 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigations
Wenger, Nanette K.
Williams, Olubunmi O.
Parashar, Susmita
SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women
title SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women
title_full SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women
title_fullStr SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women
title_full_unstemmed SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women
title_short SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women
title_sort smartwoman™: feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women
topic Clinical Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712310/
https://www.ncbi.nlm.nih.gov/pubmed/30471130
http://dx.doi.org/10.1002/clc.23124
work_keys_str_mv AT wengernanettek smartwomanfeasibilityassessmentofasmartphoneapptocontrolcardiovascularriskfactorsinvulnerablediabeticwomen
AT williamsolubunmio smartwomanfeasibilityassessmentofasmartphoneapptocontrolcardiovascularriskfactorsinvulnerablediabeticwomen
AT parasharsusmita smartwomanfeasibilityassessmentofasmartphoneapptocontrolcardiovascularriskfactorsinvulnerablediabeticwomen